Niftas Tablet SR
By Niftas
Rx
14 Tablet SR in a Strip

Composition
Nitrofurantoin(100mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
August, 2027

liver
Niftas Tablet SR should be used carefully in individuals with liver disease. It may be necessary to adjust the dose of Niftas Tablet SR in such patients. It is important to consult your doctor before taking Niftas Tablet SR if you have any liver issues. This medication is not advised for use in patients with severe liver disease or active liver disease.

kidney
Niftas Tablet SR needs caution in kidney disease. Dosage adjustments may be required. Avoid in severe kidney disease with high creatinine levels or urine retention. Always consult your doctor.

alcohol
When taking Niftas Tablet SR, avoid alcohol to prevent symptoms like flushing, increased heart rate, nausea, chest pain, and low blood pressure (Disulfiram reaction).

driving
Niftas Tablet SR may decrease alertness, affect vision, and cause drowsiness and dizziness. Avoid driving if these symptoms occur.

pregnancy
Niftas Tablet SR is generally considered safe for use during pregnancy. Animal studies have shown minimal adverse effects on the developing baby, but human studies are limited.

breastfeeding
Niftas Tablet SR needs caution during breastfeeding. Breastfeeding must be stopped until the mother finishes treatment and the drug clears her body.
Habit Forming | No |
Chemical Class | Nitrofurans derivatives |
Therapeutic Class | - |
Action Class | Urinary Antiseptic-Nitrofurantoin |
₹127.12
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024